119 related articles for article (PubMed ID: 8216670)
1. N-arylpiperazinyl derivatives of 2,3-dihydrobenzoxazin[1,4]-3-ones synthesis and normolipemic activity.
Depreux P; Moussavi Z; Lesieur D; Sauzieres J
Farmaco; 1993 Aug; 48(8):1079-89. PubMed ID: 8216670
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antihyperlipaemic activity of some novel N-cyanovinylformamidines.
Shishoo CJ; Chhabria MT; Gandhi TP; Bangaru RA
Arzneimittelforschung; 1997 Jan; 47(1):35-8. PubMed ID: 9037441
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
Kurogi Y; Inoue Y; Tsutsumi K; Nakamura S; Nagao K; Yoshitsugu H; Tsuda Y
J Med Chem; 1996 Mar; 39(7):1433-7. PubMed ID: 8691473
[TBL] [Abstract][Full Text] [Related]
7. [Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents for lowering cholesterol and triglyceride levels. Part I: Synthesis and consideration of structure-activity relationships (author's transl)].
Thiele K; Ahmed Q; Jahn U; Adrian RW
Arzneimittelforschung; 1979; 29(5):711-20. PubMed ID: 582967
[TBL] [Abstract][Full Text] [Related]
8. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
9. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives.
Idrees GA; Abuo-Rahma Gel-D; Aly OM; Radwan MF
Eur J Med Chem; 2009 Jun; 44(6):2679-84. PubMed ID: 19121550
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antihyperlipaemic activity of some 2-aminomethyl-3-aryl-5,6,7,8-tetrahydrobenzo(b)/5,6-dimethylthieno++ +(2,3- d) -pyrimidin-4-ones.
Gadad AK; Kapsi SG; Anegundi RI; Pattan SR; Mahajanshetti CS; Shishoo CJ
Arzneimittelforschung; 1996 Oct; 46(10):981-5. PubMed ID: 8931892
[TBL] [Abstract][Full Text] [Related]
12. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
[No Abstract] [Full Text] [Related]
13. [Synthesis, solubility, lipids-lowering and liver-protection activities of sulfonated formononetin].
Wang QY; Meng QH; Zhang ZT; Tian ZJ; Liu H
Yao Xue Xue Bao; 2009 Apr; 44(4):386-9. PubMed ID: 19545056
[TBL] [Abstract][Full Text] [Related]
14. Long hydrocarbon chain ether diols and ether diacids that favorably alter lipid disorders in vivo.
Mueller R; Yang J; Duan C; Pop E; Zhang LH; Huang TB; Denisenko A; Denisko OV; Oniciu DC; Bisgaier CL; Pape ME; Freiman CD; Goetz B; Cramer CT; Hopson KL; Dasseux JL
J Med Chem; 2004 Oct; 47(21):5183-97. PubMed ID: 15456261
[TBL] [Abstract][Full Text] [Related]
15. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
Metz G; Specker M
Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of 1,4-dihydropyridines with blood pressure and blood-fat lowering effects].
Zhang S; Zhao D; Mei Q; Feng R
Yao Xue Xue Bao; 1998 Oct; 33(10):789-92. PubMed ID: 12016935
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 modification by a new oxazine derivative with hypolipidemic activity.
Chrysselis MC; Rekka EA; Kourounakis PN
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):325-31. PubMed ID: 11958285
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and hypolipidemic activity of novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy) acetic acid derivatives.
Mokale SN; Sanap PT; Shinde DB
Eur J Med Chem; 2010 Jul; 45(7):3096-100. PubMed ID: 20416984
[TBL] [Abstract][Full Text] [Related]
19. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antihyperlipidemic activity of some novel 4-(substitutedamino)-5-substituted-3-mercapto- (4H)-1,2,4-triazoles.
Chhabria MT; Suhagia BN; Brahmkshatriya PS; Raval PM
Arzneimittelforschung; 2011; 61(8):452-7. PubMed ID: 21950149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
